Immunogenic composition that comprises at least 0.2 mg of recombinant Protein ORF2 of porcine circovirus type 2 (PCV2) per dose and adjuvant selected from Acrylic acid,Methacrylic acid Polymer and any of the same, which is effective to reduce the clinical symptoms associated with PCV2 infection.

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM VETMEDICA; INC.

发明人:

EICHMEYER MARK,SCHAEFFER MERRILL,NITZEL GREG

申请号：

CL2012002431

公开号：

CL2012002431A1

申请日:

2012.08.31

申请国别(地区):

CL

年份:

2012

代理人:

摘要：

Immunogenic composition that comprises at least 0.2 mg of recombinant Protein ORF2 of porcine circovirus type 2 (PCV2) per dose and adjuvant selected from Acrylic acid,Methacrylic acid Polymer and any of the same, which is effective to reduce the clinical symptoms associated with PCV2 infection (Div. Sun. 0657 - 2010).Composición inmunogénica que comprende al menos 0,2 µg de proteína recombinante ORF2 del circovirus porcino de tipo 2 (PCV2) por dosis y un adyuvante seleccionado de ácido acrílico, ácido metacrílico y cualquier polímero de los mismos, la cual es efectiva para disminuir los síntomas clínicos asociados con una infección PCV2 (Div. Sol. 0657-2010).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/